D.E. Shaw & Co’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.35M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $638K | Buy |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q2 | – | Hold |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.98M | Sell |
|
|||||
|
2023
Q3 | $1.5M | Sell |
|
|||||
|
2023
Q2 | $48.1M | Buy |
|
|||||
|
2023
Q1 | $27.2M | Buy |
|
|||||
|
2022
Q4 | $667K | Sell |
|
|||||
|
2022
Q3 | $13.5M | Buy |
|
|||||
|
2022
Q2 | $207K | Sell |
|
|||||
|
2022
Q1 | $1.68M | Sell |
|
|||||
|
2021
Q4 | $1.79M | Sell |
|
|||||
|
2021
Q3 | $2.49M | Sell |
|
|||||
|
2021
Q2 | $15.5M | Sell |
|
|||||
|
2021
Q1 | $14.4M | Sell |
|
|||||
|
2020
Q4 | $23.7M | Buy |
|
|||||
|
2020
Q3 | $11.6M | Sell |
|
|||||
|
2020
Q2 | $17.4M | Buy |
|
|||||
|
2020
Q1 | $9.9M | Buy |
|
|||||
|
2019
Q4 | $4.54M | Buy |
|
|||||
|
2019
Q3 | $267K | Buy |
|